Difference between revisions of "Team:Freiburg/Parts"

 
(27 intermediate revisions by 7 users not shown)
Line 2: Line 2:
 
{{Freiburg/Menubar}}
 
{{Freiburg/Menubar}}
  
{{Freiburg/wiki_content_start}}
+
{{Team:Freiburg/wiki_content_start_bubble}}
 
<html>
 
<html>
 
<style>
 
<style>
Line 20: Line 20:
 
</style>
 
</style>
  
 +
<script type="text/javascript">
 +
//===================BEGIN:Amazing Bubble Sidebar==========================
 +
 +
$(document).ready(function(){
 +
  // CHANGE THE FOLLOWING ATTRIBUTES //
 +
  var href_text1='https://2015.igem.org/Team:Freiburg/Results',
 +
  // Text2 needs no href as it is the actual page //
 +
  img_url='https://static.igem.org/mediawiki/2015/1/1e/Freiburg_icon_results_white_03.png',
 +
  href_text3='https://2015.igem.org/Team:Freiburg/Collaborations',
 +
  // Text1 needs no text as it is a pic //
 +
  text2='BioBricks';
 +
  // Text3 needs no text as its always 'next' //
 +
  // HOLD ON CHANGING THINGS --JABBERWOCK  //
 +
 +
  $('#bubble1').attr('href',href_text1);
 +
  $('#bubble1_img').attr('src', img_url);
 +
  $('#bubble3').attr('href',href_text3);
 +
 +
  $('#bubble2').text(text2);
 +
});
 +
 +
//===================END:Amazing Bubble Sidebar==========================
 +
</script>
  
 
<div class="content_box">
 
<div class="content_box">
Line 25: Line 48:
 
 
  
<h1 class="sectionedit1">Biobricks</h1>
+
<h1 class="sectionedit1">BioBricks</h1>
 
<div class="level1">
 
<div class="level1">
<div class="kommentar">
+
 
Hier fehlt auf jeden Fall noch die Nennung unseres Favorite Biobricks mit erklärung warum das so ist. Ich denke in unserem Fall wird das der pOP sein oder? (Stefan)</br>
+
<p>
Erster Versuch das Fav-Biobrick etwas genauer zu erklären. Verbesserungsvorschläge willkommen :) (Lara)
+
Our project involved the expression of many antigenic peptides. Their immunodominant properties make them feasible for many medical purposes. As ‘Health and Medicine’ is one of the most popular tracks chosen by iGEM Teams, we want to share the sequences encoding for these peptides with the iGEM Community. Thus, future iGEM Teams have the opportunity to take advantage of our research if they are planning to work in the field of diagnostics.
</div>
+
<br>
 +
Most of the sequences were obtained by paper research and have been synthesized by <a class="media" href="https://eu.idtdna.com/site" target="_blank" title="IDT">Integrated DNA technologies</a>, engaging their special offer for iGEM Teams. Before ordering, we used the IDT codon optimization tool to optimize the sequences for efficient expression in <i>E. coli</i>. Planning to submit the sequences to the Registry, recognition sites for restriction enzymes used for standard cloning have been removed without causing amino acid changes.
 +
<br>
 +
The group of Prof. Dr. Stefan Dübel (TU Braunschweig) provided us with an <a href="http://parts.igem.org/Part:BBa_K1621006" target="_blank">antigen specific for <i>Salmonella</i> Typhimurium</a> and a corresponding single chain variable fragment (scFv). They generated the scFv themselves after identifying the immunodominant properties of the protein. Thanks to their work we are able to provide the Registry with a specific pair of antigen and scFv.
 +
<br>
 +
All our BioBricks are summarized in the table below. Additionally, the table guides you to more detailed info pages as well as to the corresponding Registry pages.
 
<p>
 
<p>
Since our project involved expression of many antigenic peptides we decided to share those antigen-sequences with the iGEM community. We obtained most of the sequences via paper research and we would like to give special thanks to the group of Prof. Dr. Michael Hust (TU Braunschweig) who provided us with expression plasmids for the <em>Salmonella</em> Typhimurium antigen and a corresponding single chain variable fragment. The codon optimization tool from Integrated DNA Technologies was used to improve most sequences for expression in <em>E. coli</em>. We also removed all restriction sites that are not allowed in RFC[10], so that all sequences are compatible with the submission vector pSB1C3.
+
Although these parts significantly expand the <a class="media" href="http://parts.igem.org/Main_Page" target="_blank" title="Registry">Registry</a> in terms of diagnostics, none of them is our favorite BioBrick. To reach the high yields of protein expression we needed for our project we used a commercial vector optimized for inducible protein overexpression. This was unavoidable as inserting the required parts (like the lacI gene or a lacI repressible promoter) into pSB1C3 did not result in satisfying protein amounts. Most likely these problems were due to the high-copy origin of replication wasting a lot of metabolic capacity on unnecessary replication.<br>
When we started working with our first plasmids for this project, we decided to use a specific nomenclature. Every plasmid name starts with “pIG15” which is short for “plasmid igem 2015”.  
+
So far, the only plasmid backbone in the Registry with a low-copy origin of replication is <a class="urlextern" href="http://parts.igem.org/Part:pSB6A1" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:pSB6A1">pSB6A1</a>.
According to this, we named the plasmids containing our biobricks in the shipping backbone pRIG15 (“pRIG” as in “brick”)
+
  
</br>
+
<p>
</br>
+
Therefore, we developed an improved version of this plasmid backbone by combining it with a commercial expression vector. Uniting features required for efficient protein overexpression and elements related to iGEM standard cloning, we enable future iGEM Teams to perform highly productive protein overexpression based on our new backbone.
In the table below we listed all our biobricks and our biobrick improvement, pOP. We decided on pOP as our favorite biobrick because it provides the iGEM communitiy with an igem conform backbone for protein expression. When we started our project we faced the problem of pSB1C3 being a plasmid designated for cloning colliding with our need of a plasmid for expression of proteins. To be able to express proteins in a vector that exhibits all the properties of an iGEM standard backbone, we improved pSB1C3 <em>(or whatever biobrick we improved)</em> in a way that makes it possible to express proteins in <em>E.coli</em>. Details on which parts of pSB1C3 we changed and how we did this can be found <a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pOP-vector" title="pop_-_protein_expression_meets_igem_standards">here</a>.
+
<br>
 
+
Working <i>in vitro</i> is an upcoming issue in synthetic biology. The rapid development of chemical methods for gene or RNA synthesis are only examples emphasizing the importance of <i>in vitro</i> experiments. On the other side, the variety of methods for <i>in vitro</i> protein production is rather small<sup><a class="fn_top" href="#fn__1" id="fnt__1" name="fnt__1">1)</a></sup> making conventional protein expression and purification still an essential method. Therefore, pOP, the <strong>p</strong>lasmid for <strong>O</strong>verexpression of <strong>P</strong>roteins, is our favorite BioBrick.
+
<p>
 +
Find out more about the <a href="https://2015.igem.org/Team:Freiburg/Description">pOP vector </a>and check if it also meets your requirements!
 
</p>
 
</p>
 +
 
<div class="flexbox">
 
<div class="flexbox">
 
<p>
 
<p>
<a class="media" href="https://static.igem.org/mediawiki/2015/4/40/Freiburg_labjournal-cloning-biobricks.jpg" title="labjournal:cloning:biobricks.jpg"><img alt="" class="mediacenter" src="https://static.igem.org/mediawiki/2015/4/40/Freiburg_labjournal-cloning-biobricks.jpg" width="500"/></a>
+
<a class="media" href="https://static.igem.org/mediawiki/2015/4/40/Freiburg_labjournal-cloning-biobricks.jpg" title="labjournal:cloning:biobricks.jpg"><img alt="" class="mediacenter" src="https://static.igem.org/mediawiki/2015/4/40/Freiburg_labjournal-cloning-biobricks.jpg" width="700"/></a>
 
</p>
 
</p>
 
</div>
 
</div>
 
<div class="table sectionedit2"><table class="inline">
 
<div class="table sectionedit2"><table class="inline">
 
<tr class="row0">
 
<tr class="row0">
<th class="col1 leftalign"> biobrick </th><th class="col1 leftalign"> short description  </th><th class="col0 centeralign"> detailed desription  </th>
+
<th class="col1 leftalign"> BioBrick </th><th class="col1 leftalign"> short description  </th><th class="col0 centeralign"> detailed desription  </th>
 
</tr>
 
</tr>
 
<tr class="row1">
 
<tr class="row1">
<td class="col1"> <a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621000" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621000">BBa_K1621000</a></td><td class="col0"> Rubella Virus specific antigenic epitopes derived from glycoprotein E1</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_6" title="pRIG15_6">pRIG15_6</a></td>
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621009" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621009">BBa_K1621009</a></td><td class="col0"> Standardized plasmid backbone optimized for protein overexpression</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Description" title="pop_-_protein_expression_meets_igem_standards">pOP</a></td>
 
</tr>
 
</tr>
 
<tr class="row2">
 
<tr class="row2">
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621001" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621001">BBa_K1621001</a></td><td class="col0"> Varicella Zoster Virus specific antigenic epitopes derived from glycoprotein E</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_7" title="prig15_7">pRIG15_7</a></td>
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621006" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621006">BBa_K1621006</a></td><td class="col0"><i> Salmonella</i> Typhimurium specific antigenic protein (DHAD)<td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_15" title="prig15_15">pRIG15_15</a></td>
 
</tr>
 
</tr>
 
<tr class="row3">
 
<tr class="row3">
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621002" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621002">BBA_K1621002</a></td><td class="col0"> Herpes Simplex specific antigenic epitopes derived from glycoprotein G</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_8" title="prig15_8">pRIG15_8</a></td>
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621005" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621005">BBa_K1621005</a></td><td class="col0"> <i> Treponema pallidum</i> specific antigenic peptides derived from bacterioferritin (TpF1)</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_18" title="prig15_18">pRIG15_18</a></td>
 
</tr>
 
</tr>
 
<tr class="row4">
 
<tr class="row4">
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621003" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621003">BBa_K1621003</a></td><td class="col0"> <i> Clostridium tetani</i> specific antigenic epitopes derived from tetanus neurotoxin (TeNT_Hc)</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_11" title="prig15_11">pRIG15_11</a></td>
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621004" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621004">BBa_K1621004</a></td><td class="col0"> Human Immunodeficiency Virus specific antigenic epitopes derived from a polyprotein called gag/tat/pol/env</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_17" title="prig15_17">pRIG15_17</a></td>
 
</tr>
 
</tr>
 
<tr class="row5">
 
<tr class="row5">
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621004" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621004">BBa_K1621004</a></td><td class="col0"> Human Immunodeficiency Virus specific antigenic epitopes derived from a polyprotein called gag/tat/pol/env</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_17" title="prig15_17">pRIG15_17</a></td>
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621003" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621003">BBa_K1621003</a></td><td class="col0"> <i> Clostridium tetani</i> specific antigenic epitopes derived from tetanus neurotoxin (TeNT_Hc)</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_11" title="prig15_11">pRIG15_11</a></td>
 
</tr>
 
</tr>
 
<tr class="row6">
 
<tr class="row6">
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621005" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621005">BBa_K1621005</a></td><td class="col0"> <i> Treponema pallidum</i> specific antigenic peptides derived from bacterioferritin (TpF1)</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_18" title="prig15_18">pRIG15_18</a></td>
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621002" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621002">BBA_K1621002</a></td><td class="col0"> Herpes Simplex specific antigenic epitopes derived from glycoprotein G</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_8" title="prig15_8">pRIG15_8</a></td>
 
</tr>
 
</tr>
 
<tr class="row7">
 
<tr class="row7">
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621006" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621006">BBa_K1621006</a></td><td class="col0"><i> Salmonella</i> Typhimurium specific antigenic protein (DHAD)<td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_15" title="prig15_15">pRIG15_15</a></td>
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621001" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621001">BBa_K1621001</a></td><td class="col0"> Varicella Zoster Virus specific antigenic epitopes derived from glycoprotein E</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_7" title="prig15_7">pRIG15_7</a></td>
 
</tr>
 
</tr>
 
<tr class="row8">
 
<tr class="row8">
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621007" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621007">BBa_K1621007</a></td><td class="col0"> scFv binding specifically to the <i>Salmonella</i> Typhimurium derived antigen</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_13" title="prig15_13">pRIG15_13</a></td>
+
<td class="col1"> <a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621000" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621000">BBa_K1621000</a></td><td class="col0"> Rubella Virus specific antigenic epitopes derived from glycoprotein E1</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_6" title="pRIG15_6">pRIG15_6</a></td>
</tr>
+
<tr class="row9">
+
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621009" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621009">BBa_K1621009</a></td><td class="col0"> Standardized plasmid backbone optimized for protein overexpression</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pOP-vector" title="pop_-_protein_expression_meets_igem_standards">pOP</a></td>
+
 
</tr>
 
</tr>
 +
 +
 +
 +
 +
 +
 
</table></div>
 
</table></div>
  
 +
<div class="footnotes">
 +
<div class="fn"><sup><a class="fn_bot" href="#fnt__1" id="fn__1" name="fn__1">1)</a></sup>
 +
<a class="urlextern" href="http://genome.cshlp.org/content/17/1/1.full" rel="nofollow" target="_Blank" title="http://genome.cshlp.org/content/17/1/1.full">Forster and Church, 2015. Genome Research.</a></div>
  
  

Latest revision as of 02:01, 19 September 2015

""

BioBricks

Our project involved the expression of many antigenic peptides. Their immunodominant properties make them feasible for many medical purposes. As ‘Health and Medicine’ is one of the most popular tracks chosen by iGEM Teams, we want to share the sequences encoding for these peptides with the iGEM Community. Thus, future iGEM Teams have the opportunity to take advantage of our research if they are planning to work in the field of diagnostics.
Most of the sequences were obtained by paper research and have been synthesized by Integrated DNA technologies, engaging their special offer for iGEM Teams. Before ordering, we used the IDT codon optimization tool to optimize the sequences for efficient expression in E. coli. Planning to submit the sequences to the Registry, recognition sites for restriction enzymes used for standard cloning have been removed without causing amino acid changes.
The group of Prof. Dr. Stefan Dübel (TU Braunschweig) provided us with an antigen specific for Salmonella Typhimurium and a corresponding single chain variable fragment (scFv). They generated the scFv themselves after identifying the immunodominant properties of the protein. Thanks to their work we are able to provide the Registry with a specific pair of antigen and scFv.
All our BioBricks are summarized in the table below. Additionally, the table guides you to more detailed info pages as well as to the corresponding Registry pages.

Although these parts significantly expand the Registry in terms of diagnostics, none of them is our favorite BioBrick. To reach the high yields of protein expression we needed for our project we used a commercial vector optimized for inducible protein overexpression. This was unavoidable as inserting the required parts (like the lacI gene or a lacI repressible promoter) into pSB1C3 did not result in satisfying protein amounts. Most likely these problems were due to the high-copy origin of replication wasting a lot of metabolic capacity on unnecessary replication.
So far, the only plasmid backbone in the Registry with a low-copy origin of replication is pSB6A1.

Therefore, we developed an improved version of this plasmid backbone by combining it with a commercial expression vector. Uniting features required for efficient protein overexpression and elements related to iGEM standard cloning, we enable future iGEM Teams to perform highly productive protein overexpression based on our new backbone.
Working in vitro is an upcoming issue in synthetic biology. The rapid development of chemical methods for gene or RNA synthesis are only examples emphasizing the importance of in vitro experiments. On the other side, the variety of methods for in vitro protein production is rather small1) making conventional protein expression and purification still an essential method. Therefore, pOP, the plasmid for Overexpression of Proteins, is our favorite BioBrick.

Find out more about the pOP vector and check if it also meets your requirements!

BioBrick short description detailed desription
BBa_K1621009 Standardized plasmid backbone optimized for protein overexpressionpOP
BBa_K1621006 Salmonella Typhimurium specific antigenic protein (DHAD)pRIG15_15
BBa_K1621005 Treponema pallidum specific antigenic peptides derived from bacterioferritin (TpF1)pRIG15_18
BBa_K1621004 Human Immunodeficiency Virus specific antigenic epitopes derived from a polyprotein called gag/tat/pol/envpRIG15_17
BBa_K1621003 Clostridium tetani specific antigenic epitopes derived from tetanus neurotoxin (TeNT_Hc)pRIG15_11
BBA_K1621002 Herpes Simplex specific antigenic epitopes derived from glycoprotein GpRIG15_8
BBa_K1621001 Varicella Zoster Virus specific antigenic epitopes derived from glycoprotein EpRIG15_7
BBa_K1621000 Rubella Virus specific antigenic epitopes derived from glycoprotein E1pRIG15_6